Igor Hartmann

About

Igor Hartmann is a pioneering urologic surgeon whose research focuses on advancing robotic-assisted surgical techniques for prostate and kidney cancers. His most impactful contribution is the development and clinical validation of the Advanced Reconstruction of Vesicourethral Support (ARVUS) technique during robot-assisted radical prostatectomy. In a landmark two-group randomised controlled trial (2016, 77 citations), Hartmann demonstrated that ARVUS significantly improves one-year functional outcomes, particularly in early continence recovery, setting a new standard for post-prostatectomy quality of life. His work extends to renal oncology, where he investigates the frequency of benign tumors after partial nephrectomy (2024), aiming to refine preoperative risk stratification and reduce unnecessary surgeries. Hartmann also contributed to the early adoption of robot-assisted partial nephrectomy (RAPN) in Central Europe, authoring foundational Czech-language studies on the procedure. By combining rigorous trial design with a focus on patient-centered functional outcomes, Hartmann has shaped modern urologic practice. His research bridges surgical innovation and evidence-based medicine, offering tangible improvements in recovery for thousands of patients undergoing robotic cancer surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Advanced Reconstruction of Vesicourethral Support (ARVUS) during Robot-assisted Radical Prostatectomy: One-year Functional Outcomes in a Two-group Randomised Controlled Trial

   77 citations · 2016
2. 2
   Frequency of benign tumors after partial nephrectomy and the association between malignant tumor findings and preoperative clinical parameters

   3 citations · 2024
3. 3
   Roboticky asistovaná resekce ledviny pro tumor

   2 citations · 2016

Key Collaborators

Contact & Links